rs146205352

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_181882.3(PRX):​c.3838G>C​(p.Glu1280Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,599,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0013 ( 0 hom., cov: 32)
Exomes š‘“: 0.00013 ( 0 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.27
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.009347498).
BP6
Variant 19-40394514-C-G is Benign according to our data. Variant chr19-40394514-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 543486.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00127 (193/152286) while in subpopulation AFR AF= 0.00452 (188/41558). AF 95% confidence interval is 0.00399. There are 0 homozygotes in gnomad4. There are 89 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRXNM_181882.3 linkc.3838G>C p.Glu1280Gln missense_variant Exon 7 of 7 ENST00000324001.8 NP_870998.2 Q9BXM0-1
PRXNM_001411127.1 linkc.4123G>C p.Glu1375Gln missense_variant Exon 7 of 7 NP_001398056.1
PRXXM_017027047.2 linkc.3736G>C p.Glu1246Gln missense_variant Exon 4 of 4 XP_016882536.1
PRXNM_020956.2 linkc.*4043G>C 3_prime_UTR_variant Exon 6 of 6 NP_066007.1 Q9BXM0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkc.3838G>C p.Glu1280Gln missense_variant Exon 7 of 7 1 NM_181882.3 ENSP00000326018.6 Q9BXM0-1

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
193
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00454
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000311
AC:
69
AN:
221994
Hom.:
0
AF XY:
0.000215
AC XY:
26
AN XY:
121198
show subpopulations
Gnomad AFR exome
AF:
0.00489
Gnomad AMR exome
AF:
0.0000624
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000180
GnomAD4 exome
AF:
0.000129
AC:
187
AN:
1447668
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
78
AN XY:
719500
show subpopulations
Gnomad4 AFR exome
AF:
0.00501
Gnomad4 AMR exome
AF:
0.0000700
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000301
GnomAD4 genome
AF:
0.00127
AC:
193
AN:
152286
Hom.:
0
Cov.:
32
AF XY:
0.00120
AC XY:
89
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00452
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.000581
Hom.:
0
Bravo
AF:
0.00137
ESP6500AA
AF:
0.00342
AC:
15
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000355
AC:
43
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Dec 17, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The PRX c.3838G>C; p.Glu1280Gln variant (rs146205352), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 543486). This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.45 percent in the African population (identified on 100 out of 22,178 chromosomes). The glutamic acid at position 1280 is highly conserved and computational analyses of the effects of the p.Glu1280Gln variant on protein structure and function is conflicting (SIFT: tolerated, PolyPhen-2: probably damaging). In addition computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site/weakening the nearby canonical splice site. Overall, there is not enough evidence to classify the p.Glu1280Gln variant with certainty. -

PRX-related disorder Benign:1
Jun 23, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Oct 19, 2020
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Charcot-Marie-Tooth disease type 4 Benign:1
Oct 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.29
T
Eigen
Benign
0.095
Eigen_PC
Benign
-0.030
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.049
Sift
Benign
0.22
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.41
MVP
0.65
MPC
0.54
ClinPred
0.037
T
GERP RS
3.8
Varity_R
0.13
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146205352; hg19: chr19-40900421; API